Evidence map›Paper›PMID 28428565›Full record

ArticleScientific reports2017

Small methyltransferase RlmH assembles a composite active site to methylate a ribosomal pseudouridine.

Cha San Koh, Rohini Madireddy, Timothy J Beane, Phillip D Zamore, Andrei A Korostelev

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cha San KohRNA Therapeutics Institute, University of Massachusetts Medical School, 368 Plantation St, Worcester, MA 01605, USA.
Rohini MadireddyRNA Therapeutics Institute, University of Massachusetts Medical School, 368 Plantation St, Worcester, MA 01605, USA.
Timothy J BeaneRNA Therapeutics Institute, University of Massachusetts Medical School, 368 Plantation St, Worcester, MA 01605, USA.
Phillip D ZamoreRNA Therapeutics Institute, Howard Hughes Medical Institute, University of Massachusetts Medical School, 368 Plantation St, Worcester, MA 01605, USA. phillip.zamore@umassmed.edu.
Andrei A KorostelevRNA Therapeutics Institute, University of Massachusetts Medical School, 368 Plantation St, Worcester, MA 01605, USA. andrei.korostelev@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Understanding the Mechanism of RNA InterferenceR37GM062862 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZAMORE, PHILLIP D · 2010 to 2019
$5.3M
Structural bases for cellular stress responses mediated by stalled translationR01GM106105 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOROSTELEV, ANDREI · 2013 to 2017
$1.6M
Molecular principles of translation terminationR01GM107465 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOROSTELEV, ANDREI · 2015 to 2018
$1.3M
Asymmetric flow FFF and Composition Gradient/Light Scattering SystemS10RR023748 · NCRR · YALE UNIVERSITY · PI FOLTA-STOGNIEW, EWA JOANNA · 2007 to 2007
$271k
NCRR NIH HHS S10 RR023748NIGMS NIH HHS R01 GM106105NIGMS NIH HHS R01 GM107465NIGMS NIH HHS R37 GM062862
6 · The paper itself

Abstract

Eubacterial ribosomal large-subunit methyltransferase H (RlmH) methylates 23S ribosomal RNA pseudouridine 1915 (Ψ1915), which lies near the ribosomal decoding center. The smallest member of the SPOUT superfamily of methyltransferases, RlmH lacks the RNA recognition domain found in larger methyltransferases. The catalytic mechanism of RlmH enzyme is unknown. Here, we describe the structures of RlmH bound to S-adenosyl-methionine (SAM) and the methyltransferase inhibitor sinefungin. Our structural and biochemical studies reveal catalytically essential residues in the dimer-mediated asymmetrical active site. One monomer provides the SAM-binding site, whereas the conserved C-terminal tail of the second monomer provides residues essential for catalysis. Our findings elucidate the mechanism by which a small protein dimer assembles a functionally asymmetric architecture.

Indexed as

AdenosineBinding SitesCatalytic DomainEscherichia coliEscherichia coli ProteinsMethylationMethyltransferasesModels, MolecularMutationProtein BindingProtein MultimerizationProtein Structure, SecondaryPseudouridineRNA, Ribosomal, 23SS-AdenosylmethionineSubstrate SpecificityAdenosineEscherichia coli ProteinsMethyltransferasesPseudouridineRlmH protein, E coliRNA, Ribosomal, 23SS-Adenosylmethioninesinefungin

Identifiers

PMID28428565
PMCPMC5430550
OpenAlexW2606353465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.